NEUBASE THERAPEUTICS, INC.

Profile

Company Names

NEUBASE THERAPEUTICS, INC.
OHR PHARMACEUTICAL INC
BBM HOLDINGS, INC.

Addresses

350 TECHNOLOGY DRIVE, PITTSBURGH, PA 15219

800 THIRD AVENUE, 11TH FLOOR, NEW YORK, NY 10022

489 FIFTH AVENUE, NEW YORK,, NY 10017

1245 BRICKYARD ROAD #590, SALT LAKE CITY, UT 84106

Phone Numbers

412-763-3350
212-682-8452
801-433-2000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

UT

Total Amount Raised:

$17,681,722.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2023-06-28 
$5,000,002.00 
$5,000,002.00 
$0.00 
Equity 
6
2014-12-24 
$50,000.00 
$50,000.00 
$0.00 
Equity 
5
2014-05-30 
$10,180,224.00 
$25,180,224.00 
$15,000,000.00 
Equity 
4
2013-12-30 
$569,581.00 
$569,581.00 
$0.00 
 
3
2013-10-02 
$376,915.00 
$376,915.00 
$0.00 
Equity 
2
2009-06-03 
$1,005,000.00 
$1,080,000.00 
$75,000.00 
Equity 
1
2009-03-19 
$500,000.00 
$500,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JUNE 
 
ALMENOFF 
DIRECTOR
OHR PHARMACEUTICAL INC   |  TIGENIX NV   |  REDHILL BIOPHARMA LTD.   |  TENAX THERAPEUTICS, INC.
SAM 
 
BACKENROTH 
EXECUTIVE OFFICER
OHR PHARMACEUTICAL INC
TODD 
 
BRANNING 
EXECUTIVE OFFICER
NEUBASE THERAPEUTICS, INC.
DOV 
 
GOLDSTEIN 
DIRECTOR
CEMPRA HOLDINGS, LLC   |  BIORELIX INC   |  ESPERION THERAPEUTICS, INC.   |  CEMPRA, INC.   |  LOXO ONCOLOGY, INC.   |  GEOM THERAPEUTICS, INC.   |  COYA THERAPEUTICS, INC.   |  NEUBASE THERAPEUTICS, INC.   |  BIOAGE LABS, INC.
IRA 
 
GREENSTEIN 
DIRECTOR, EXECUTIVE OFFICER
BBM HOLDINGS, INC.   |  NANO VIBRONIX, INC.   |  DOCUMENT SECURITY SYSTEMS INC   |  OHR PHARMACEUTICAL INC   |  NANOVIBRONIX, INC.
ORIN 
 
HIRSCHMAN 
DIRECTOR, EXECUTIVE OFFICER
BBM HOLDINGS, INC.   |  OHR PHARMACEUTICAL INC   |  AIGH INVESTMENT PARTNERS, L.P.
ANDREW 
 
LIMPERT 
DIRECTOR, EXECUTIVE OFFICER
BBM HOLDINGS, INC.
GERALD 
 
MCDOUGALL 
DIRECTOR
NEUBASE THERAPEUTICS, INC.
FRANKLYN 
 
PRENDERGAST 
DIRECTOR
CELLUMEN, INC.   |  CERNOSTICS PATHOLOGY, INC.   |  CERNOSTICS, INC.   |  LIQUID BIOSCIENCE, INC.   |  NEUBASE THERAPEUTICS, INC.
ERIC 
 
RICHMAN 
DIRECTOR
THERABRON THERAPEUTICS, INC.   |  LABCONNECT HOLDINGS, INC.   |  INFUSE HOLDINGS, INC.   |  ZYVERSA THERAPEUTICS, INC.   |  NEUBASE THERAPEUTICS, INC.
THOMAS 
 
RIEDHAMMER 
DIRECTOR
SIRION HOLDINGS, INC.   |  SIRION HOLDINGS, INC.   |  OHR PHARMACEUTICAL INC
DIETRICH 
 
STEPHAN 
EXECUTIVE OFFICER, DIRECTOR
DIAVACS, INC.   |  FOCUSED GENOMICS, INC.   |  PEPTILOGICS, INC.   |  FARMACEUTICALRX, LLC   |  FRX GROWTH PARTNERS, LLC   |  FARMACEUTICALRX, LLC   |  NEUBASE THERAPEUTICS, INC.
IRACH 
 
TARAPOREWALA 
EXECUTIVE OFFICER, DIRECTOR
OHR PHARMACEUTICAL INC   |  IMMUNOCELLULAR THERAPEUTICS, LTD.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-07-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2023-06-28 
2014-12-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2014-12-24 
2014-06-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2014-05-30 
2014-01-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2013-12-30 
2013-10-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-10-02 
2009-06-04
D
Link
BIOTECHNOLOGY 
COMMUNICATIONS EQUIPMENT, NEC [3669] 
NO REVENUES 
Equity 
2009-06-03 
2009-04-03
D
Link
BIOTECHNOLOGY 
COMMUNICATIONS EQUIPMENT, NEC [3669] 
NO REVENUES 
Debt 
2009-03-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375